| | | |   | | | | By Ed Silverman Adobe "We're fighting back against drug companies and PBMs that... inflate the cost of life-saving medication,” said California's attorney general. Read More | | By John Wilkerson SAUL LOEB/POOL/AFP via Getty Images The FTC is hoping to expand its authority to crack down on unfair business practices, a shift that has implications for its scrutiny of PBMs. Read More | | By Jason Mast and Matthew Herper Ruby Wallau/STAT Under pressure, the CEO has been meeting with dozens of drugmakers in San Francisco to find partners for his synthetic biology platform. Read More | | Sponsored Insight by Pfizer Harnessing the Power of Blockchain to Transform Value in Healthcare Years of rising costs, along with unprecedented innovation, have fundamentally transformed the healthcare system, signaling the urgent need to change the way we pay for healthcare products and services. Learn how Pfizer is leveraging blockchain technology to execute value-based agreements more efficiently — helping to modernize healthcare delivery, save costs and improve patient outcomes. | | By Ed Silverman Alex Hogan/STAT From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. Read More | |
No comments